Anika Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
Anika Therapeutics, Inc. (ANIK) reported Increase (Decrease) in Deferred Revenue of -$50.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2017-02-24
- Anika Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2016-12-31 was -$7.00K.
- Anika Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2016-09-30 was $2.00K.
- Anika Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2016-06-30 was -$6.00K.
- Anika Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2016-03-31 was -$39.00K, a 134.82% decline year-over-year.
- Anika Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2016 was -$50.00K.
- Anika Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2015 was -$15.00K.
- Anika Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2014 was -$2.01M.
- Anika Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2013 was -$2.79M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$5.00K derived: sum of 2 quarters · filed 2017-02-24 | -$11.00K derived: sum of 3 quarters · filed 2017-02-24 | -$50.00K 10-K · filed 2017-02-24 | ||||
| 2016-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$4.00K derived: sum of 2 quarters · filed 2016-11-01 | -$43.00K 10-Q · filed 2016-11-01 | -$49.00K derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2016-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | -$45.00K 10-Q · filed 2016-08-01 | -$51.00K derived: sum of 3 quarters · filed 2017-02-24 | -$55.00K derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2016-03-31 | -$39.00K 10-Q · filed 2016-05-03 | -$45.00K derived: sum of 2 quarters · filed 2017-02-24 | -$49.00K derived: sum of 3 quarters · filed 2017-02-24 | -$166.00K derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$10.00K derived: sum of 2 quarters · filed 2017-02-24 | -$127.00K derived: sum of 3 quarters · filed 2017-02-24 | -$15.00K 10-K · filed 2017-02-24 | ||||
| 2015-09-30 | -$4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$121.00K derived: sum of 2 quarters · filed 2016-11-01 | -$9.00K 10-Q · filed 2016-11-01 | -$9.13K 10-Q · filed 2015-11-03 | $55.54K derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-06-30 | -$117.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | -$5.00K 10-Q · filed 2016-08-01 | -$5.48K 10-Q · filed 2015-08-04 | $59.54K derived: sum of 3 quarters · filed 2017-02-24 | $121.90K derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2015-03-31 | $112.00K 10-Q · filed 2016-05-03 | $111.70K 10-Q · filed 2015-05-04 | $176.54K derived: sum of 2 quarters · filed 2017-02-24 | $238.90K derived: sum of 3 quarters · filed 2017-02-24 | $211.09K derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $64.54K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $126.90K derived: sum of 2 quarters · filed 2017-02-24 | $99.09K derived: sum of 3 quarters · filed 2017-02-24 | -$2.01M 10-K · filed 2017-02-24 | -$2.01M 10-K · filed 2015-03-13 | |||
| 2014-09-30 | $62.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $34.54K derived: sum of 2 quarters · filed 2015-11-03 | -$2.08M 10-Q · filed 2015-11-03 | -$2.72M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | -$27.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$2.14M 10-Q · filed 2015-08-04 | -$2.79M derived: sum of 3 quarters · filed 2016-03-10 | -$3.51M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | -$2.11M 10-Q · filed 2015-05-04 | -$2.76M derived: sum of 2 quarters · filed 2016-03-10 | -$3.48M derived: sum of 3 quarters · filed 2016-03-10 | -$4.18M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | -$645.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$1.36M derived: sum of 2 quarters · filed 2016-03-10 | -$2.07M derived: sum of 3 quarters · filed 2016-03-10 | -$2.79M 10-K · filed 2016-03-10 | -$2.80M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | -$719.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$1.42M derived: sum of 2 quarters · filed 2014-11-06 | -$2.15M 10-Q · filed 2014-11-06 | -$2.86M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | -$705.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$1.43M 10-Q · filed 2014-08-04 | -$2.14M derived: sum of 3 quarters · filed 2015-03-13 | -$2.86M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | -$725.07K 10-Q · filed 2014-05-05 | -$1.43M derived: sum of 2 quarters · filed 2015-03-13 | -$2.15M derived: sum of 3 quarters · filed 2015-03-13 | -$2.87M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | -$708.26K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$1.42M derived: sum of 2 quarters · filed 2015-03-13 | -$2.14M derived: sum of 3 quarters · filed 2015-03-13 | -$2.86M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | -$716.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$1.43M derived: sum of 2 quarters · filed 2013-11-05 | -$2.15M 10-Q · filed 2013-11-05 | -$479.58K derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | -$716.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$1.43M 10-Q · filed 2013-08-06 | $237.09K derived: sum of 3 quarters · filed 2014-03-13 | -$304.75K derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | -$716.67K 10-Q · filed 2013-05-06 | $953.75K derived: sum of 2 quarters · filed 2014-03-13 | $411.92K derived: sum of 3 quarters · filed 2014-03-13 | -$262.37K derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $1.13M derived: sum of 2 quarters · filed 2014-03-13 | $454.30K derived: sum of 3 quarters · filed 2014-03-13 | -$213.89K 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | -$541.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$1.22M derived: sum of 2 quarters · filed 2012-11-08 | -$1.88M 10-Q · filed 2012-11-08 | -$2.56M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | -$674.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$1.34M 10-Q · filed 2012-08-07 | -$2.02M derived: sum of 3 quarters · filed 2013-03-14 | -$2.69M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | -$668.19K 10-Q · filed 2012-05-07 | -$1.34M derived: sum of 2 quarters · filed 2013-03-14 | -$2.02M derived: sum of 3 quarters · filed 2013-03-14 | |||||
| 2010-12-31 | -$675.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | -$1.35M derived: sum of 2 quarters · filed 2013-03-14 | -$2.75M 10-K · filed 2013-03-14 | |||||
| 2010-09-30 | -$675.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-04 | -$2.08M 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | -$1.40M 10-Q/A · filed 2011-08-10 | |||||||
| 2009-12-31 | -$2.68M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |